Tumor initiating cells in Esophageal squamous cell carcinomas express high levels of CD44

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Zhao, Jiang Sha ^a   Li, Wen Jie ^b   Ge, Di ^c   Zhang, Pei Jing ^a   Li, Jing Jing ^a   Lu, Chun Lai ^c   Ji, Xiao Dan ^a   Guan, Dong Xian ^a   Gao, Hong ^a   Xu, Li Yan ^d   Li, Eng Ming ^d   Soukiasian, Harmik ^e   Koeffler, H Phillip ^f   Wang, Xiao Fan ^g   Xie, Dong ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD271 ANTIGEN; CELL SURFACE PROTEIN; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; THY 1 ANTIGEN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CD44 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CELL POPULATION; COLONY FORMATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR INITIATING CELL; TUMOR VOLUME; ANIMAL; CELL DEATH; CELL DIFFERENTIATION; DOWN REGULATION; DRUG EFFECT; ESOPHAGUS TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

MUS;

ADULT; ANIMALS; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL DEATH; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; NEOPLASTIC STEM CELLS;

EID: 79959590586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021419     Document Type: Article

References (40)

1. Vizcaino AP, Moreno V, Lambert R, Parkin DM, (2002) Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 99: 860-868.
2. Ke L, (2002) Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90. Int J Cancer 102: 271-274.
3. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
4. Enzinger PC, Mayer RJ, (2003) Esophageal cancer. N Engl J Med 349: 2241-2252.
5. Frank NY, Schatton T, Frank MH, (2010) The therapeutic promise of the cancer stem cell concept. J Clin Invest 120: 41-50.
6. Bonnet D, Dick JE, (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737.
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
8. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, et al. (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104: 10158-10163.
9. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
10. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
11. Yamashita T, Ji J, Budhu A, Forgues M, Yang W, et al. (2009) EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136: 1012-1024.
12. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, et al. (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328-9337.
13. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, et al. (2006) Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25: 1696-1708.
14. Du L, Wang H, He L, Zhang J, Ni B, et al. (2008) CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 14: 6751-6760.
15. Huang D, Gao Q, Guo L, Zhang C, Jiang W, et al. (2009) Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev 18: 465-473.
16. Huang SD, Yuan Y, Liu XH, Gong DJ, Bai CG, et al. (2009) Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas. BMC Cancer 9: 9.
17. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, et al. (2008) Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13: 153-166.
18. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, et al. (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 104: 973-978.
19. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, et al. (2009) Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27: 1006-1020.
20. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, et al. (2007) Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037.
21. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
22. Reim F, Dombrowski Y, Ritter C, Buttmann M, Hausler S, et al. (2009) Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells. Cancer Res 69: 8058-8066.
23. Roye GD, Myers RB, Brown D, Poczatek R, Beenken SW, et al. (1996) CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int J Cancer 69: 254-258.
24. Gotoda T, Matsumura Y, Kondo H, Ono H, Kanamoto A, et al. (2000) Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gut 46: 14-19.
25. Wong FH, Huang CY, Su LJ, Wu YC, Lin YS, et al. (2009) Combination of microarray profiling and protein-protein interaction databases delineates the minimal discriminators as a metastasis network for esophageal squamous cell carcinoma. Int J Oncol 34: 117-128.
26. Liu WK, Fu Q, Li YM, Jiang XY, Zhang MP, et al. (2009) The relationship between cyclooxygenase-2, CD44v6, and nm23H1 in esophageal squamous cell carcinoma. Onkologie 32: 574-578.
27. Nozoe T, Kohnoe S, Ezaki T, Kabashima A, Maehara Y, (2004) Significance of immunohistochemical over-expression of CD44v6 as an indicator of malignant potential in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 130: 334-338.
28. Dalerba P, Cho RW, Clarke MF, (2007) Cancer stem cells: models and concepts. Annu Rev Med 58: 267-284.
29. Burkert J, Otto WR, Wright NA, (2008) Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol 214: 564-573.
30. Lichtenauer UD, Shapiro I, Geiger K, Quinkler M, Fassnacht M, et al. (2008) Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R. Endocrinology 149: 1314-1322.
31. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, et al. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567-572.
32. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, et al. (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76: 1704-1709.
33. Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, et al. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324: 1385-1393.
34. Soprano DR, Teets BW, Soprano KJ, (2007) Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells. Vitam Horm 75: 69-95.
35. Duester G, (2008) Retinoic acid synthesis and signaling during early organogenesis. Cell 134: 921-931.
36. Cooke G, Blanco-Fernandez A, Seery JP, (2008) The effect of retinoic acid and deoxycholic acid on the differentiation of primary human esophageal keratinocytes. Dig Dis Sci 53: 2851-2857.
37. Muller A, Nakagawa H, Rustgi AK, (1997) Retinoic acid and N-(4-hydroxy-phenyl) retinamide suppress growth of esophageal squamous carcinoma cell lines. Cancer Lett 113: 95-101.
38. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R, (1999) Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res 59: 2477-2483.
39. Shimizu M, Suzui M, Deguchi A, Lim JT, Weinstein IB, (2004) Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells. Clin Cancer Res 10: 1130-1140.
40. Zhou ZQ, Cao WH, Xie JJ, Lin J, Shen ZY, et al. (2009) Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer 9: 291.